References
1. Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, et al. Hand, foot,
and mouth disease in China, 2008–12: an epidemiological study. The
Lancet Infectious Diseases. 2014;14(4):308-18.
2. Zhou X, Zhu Q, Xia W, He F, Hu M, Ni X, et al. Molecular epidemiology
of an outbreak of hand, foot, and mouth disease associated with
subgenotype C4a of enterovirus A71 in Nanchang, China in 2014. J Med
Virol. 2015;87(12):2154-8.
3. Zhu P, Ji W, Li D, Li Z, Chen Y, Dai B, et al. Current status of
hand-foot-and-mouth disease. J Biomed Sci. 2023;30(1):15.
4. Palacios G, Oberste MS. Enteroviruses as agents of emerging
infectious diseases. J Neurovirol. 2005;11(5):424-33.
5. Wang SM, Liu CC, Tseng HW, Wang JR, Huang CC, Chen YJ, et al.
Clinical spectrum of enterovirus 71 infection in children in southern
Taiwan, with an emphasis on neurological complications. Clin Infect Dis.
1999;29(1):184-90.
6. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH.
Virology, epidemiology, pathogenesis, and control of enterovirus 71.
Lancet Infect Dis. 2010;10(11):778-90.
7. Feng X, Guan W, Guo Y, Yu H, Zhang X, Cheng R, et al. A novel
recombinant lineage’s contribution to the outbreak of coxsackievirus
A6-associated hand, foot and mouth disease in Shanghai, China,
2012-2013. Sci Rep. 2015;5:11700.
8. Kamau E, Nguyen D, Celma C, Blomqvist S, Horby P, Simmonds P, et al.
Seroprevalence and Virologic Surveillance of Enterovirus 71 and
Coxsackievirus A6, United Kingdom, 2006-2017. Emerg Infect Dis.
2021;27(9):2261-8.
9. Liu H, Zhang M, Feng C, Cong S, Xu D, Sun H, et al. Characterization
of Coxsackievirus A6 Strains Isolated From Children With Hand, Foot, and
Mouth Disease. Front Cell Infect Microbiol. 2021;11:700191.
10. Tomba Ngangas S, Bisseux M, Jugie G, Lambert C, Cohen R, Werner A,
et al. Coxsackievirus A6 Recombinant Subclades D3/A and D3/H Were
Predominant in Hand-Foot-And-Mouth Disease Outbreaks in the Paediatric
Population, France, 2010-2018. Viruses. 2022;14(5).
11. Kanbayashi D, Kaida A, Yamamoto SP, Hirai Y, Kubo H, Fujimori R, et
al. Impact of Coxsackievirus A6 emergence on hand, foot, and mouth
disease epidemic in Osaka City, Japan. J Med Virol. 2017;89(12):2116-21.
12. He F, Rui J, Deng Z, Zhang Y, Qian K, Zhu C, et al. Surveillance,
Epidemiology and Impact of EV-A71 Vaccination on Hand, Foot, and Mouth
Disease in Nanchang, China, 2010-2019. Front Microbiol. 2021;12:811553.
13. Zhao Z, Zheng C, Qi H, Chen Y, Ward MP, Liu F, et al. Impact of the
coronavirus disease 2019 interventions on the incidence of hand, foot,
and mouth disease in mainland China. Lancet Reg Health West Pac.
2022;20:100362.
14. Yang Y, Yu M. Response to global public health emergency: Overview
and lessons from Chinese experience against COVID-19. J Glob Health.
2023;13:03016.
15. Li Y, Chang Z, Wu P, Liao Q, Liu F, Zheng Y, et al. Emerging
Enteroviruses Causing Hand, Foot and Mouth Disease, China, 2010-2016.
Emerg Infect Dis. 2018;24(10):1902-6.
16. Ge S, Yan Q, He S, Zhuang S, Niu J, Xia N. Specific primer
amplification of the VP1 region directed by 5’ UTR sequence analysis:
enterovirus testing and identification in clinical samples from
hand-foot-and-mouth disease patients. J Virol Methods.
2013;193(2):463-9.
17. Ji T, Han T, Tan X, Zhu S, Yan D, Yang Q, et al. Surveillance,
epidemiology, and pathogen spectrum of hand, foot, and mouth disease in
mainland of China from 2008 to 2017. Biosafety and Health.
2019;1(1):32-40.
18. Gao LD, Hu SX, Zhang H, Luo KW, Liu YZ, Xu QH, et al. Correlation
analysis of EV71 detection and case severity in hand, foot, and mouth
disease in the Hunan Province of China. PLoS One. 2014;9(6):e100003.
19. Chen JF, Zhang RS, Ou XH, Chen FM, Sun BC. The role of enterovirus
71 and coxsackievirus A strains in a large outbreak of hand, foot, and
mouth disease in 2012 in Changsha, China. Int J Infect Dis.
2014;28:17-25.
20. Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, et al. An inactivated
enterovirus 71 vaccine in healthy children. N Engl J Med.
2014;370(9):829-37.
21. Nickbakhsh S, Mair C, Matthews L, Reeve R, Johnson PCD, Thorburn F,
et al. Virus-virus interactions impact the population dynamics of
influenza and the common cold. Proc Natl Acad Sci U S A.
2019;116(52):27142-50.
22. Staring J, van den Hengel LG, Raaben M, Blomen VA, Carette JE,
Brummelkamp TR. KREMEN1 Is a Host Entry Receptor for a Major Group of
Enteroviruses. Cell Host Microbe. 2018;23(5):636-43 e5.
23. Tang Q, Xu Z, Zhang F, Cai Y, Chen Y, Lu B, et al. Identification of
a novel binding inhibitor that blocks the interaction between hSCARB2
and VP1 of enterovirus 71. Cell Insight. 2022;1(2).
24. Head JR, Collender PA, Lewnard JA, Skaff NK, Li L, Cheng Q, et al.
Early evidence of inactivated enterovirus 71 vaccine impact against
hand, foot, and mouth disease in a major center of ongoing transmission
in China, 2011-2018: a longitudinal surveillance study. Clin Infect Dis.
2019.
25. Song Y, Zhang Y, Ji T, Gu X, Yang Q, Zhu S, et al. Persistent
circulation of Coxsackievirus A6 of genotype D3 in mainland of China
between 2008 and 2015. Sci Rep. 2017;7(1):5491.
26. Wang J, Teng Z, Cui X, Li C, Pan H, Zheng Y, et al. Epidemiological
and serological surveillance of hand-foot-and-mouth disease in Shanghai,
China, 2012-2016. Emerg Microbes Infect. 2018;7(1):8.